Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits.

Document Type

Article

Publication Date

1-1-2001

Abstract

The study reaffirms the safety and efficacy of the Vi polysaccharide vaccine and identifies a hitherto unrecognized advantage in its use, i.e. it is a potent immunogen that boosted considerably the protective antibody levels among a significant number of immunologically sensitized individuals living in typhoid-endemic regions.

Keywords

Adolescent, Adult

Divisions

fac_med

Publication Title

Bulletin of the World Health Organization

Volume

79

Issue

9

This document is currently not available here.

Share

COinS